Logo image of Z

ZILLOW GROUP INC - C (Z) Stock Fundamental Analysis

USA - NASDAQ:Z - US98954M2008 - Common Stock

68.22 USD
+0.9 (+1.34%)
Last: 11/19/2025, 2:58:31 PM
Fundamental Rating

5

Z gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. Z has a great financial health rating, but its profitability evaluates not so good. Z is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year Z was profitable.
Z had a positive operating cash flow in the past year.
In the past 5 years Z always reported negative net income.
Of the past 5 years Z 4 years had a positive operating cash flow.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

The Return On Assets of Z (-0.56%) is comparable to the rest of the industry.
With a Return On Equity value of -0.64%, Z perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
ROA -0.56%
ROE -0.64%
ROIC N/A
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

Looking at the Gross Margin, with a value of 74.87%, Z belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
Z's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for Z so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, Z has more shares outstanding
The number of shares outstanding for Z has been increased compared to 5 years ago.
Compared to 1 year ago, Z has an improved debt to assets ratio.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Z has an Altman-Z score of 14.30. This indicates that Z is financially healthy and has little risk of bankruptcy at the moment.
Z has a Altman-Z score of 14.30. This is amongst the best in the industry. Z outperforms 95.24% of its industry peers.
Z has a debt to FCF ratio of 1.83. This is a very positive value and a sign of high solvency as it would only need 1.83 years to pay back of all of its debts.
Z's Debt to FCF ratio of 1.83 is amongst the best of the industry. Z outperforms 84.13% of its industry peers.
Z has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Z's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. Z outperforms 79.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.83
Altman-Z 14.3
ROIC/WACCN/A
WACC8.35%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

Z has a Current Ratio of 3.63. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
Z has a better Current ratio (3.63) than 82.54% of its industry peers.
Z has a Quick Ratio of 3.63. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of Z (3.63) is better than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 3.63
Quick Ratio 3.63
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.92% over the past year.
Looking at the last year, Z shows a quite strong growth in Revenue. The Revenue has grown by 15.17% in the last year.
Measured over the past years, Z shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)16.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
Revenue 1Y (TTM)15.17%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.35%

3.2 Future

The Earnings Per Share is expected to grow by 30.58% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.16% on average over the next years. This is quite good.
EPS Next Y22.85%
EPS Next 2Y27.79%
EPS Next 3Y29.97%
EPS Next 5Y30.58%
Revenue Next Year15.76%
Revenue Next 2Y14.95%
Revenue Next 3Y14.6%
Revenue Next 5Y14.16%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 44.88, Z can be considered very expensive at the moment.
Z's Price/Earnings ratio is a bit cheaper when compared to the industry. Z is cheaper than 68.25% of the companies in the same industry.
Z is valuated expensively when we compare the Price/Earnings ratio to 25.47, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 30.49, which means the current valuation is very expensive for Z.
Compared to the rest of the industry, the Price/Forward Earnings ratio of Z indicates a somewhat cheap valuation: Z is cheaper than 76.19% of the companies listed in the same industry.
Z is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 35.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 44.88
Fwd PE 30.49
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Z's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of Z indicates a somewhat cheap valuation: Z is cheaper than 61.90% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 110.92
EV/EBITDA 84.53
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates Z does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as Z's earnings are expected to grow with 29.97% in the coming years.
PEG (NY)1.96
PEG (5Y)N/A
EPS Next 2Y27.79%
EPS Next 3Y29.97%

0

5. Dividend

5.1 Amount

Z does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZILLOW GROUP INC - C

NASDAQ:Z (11/19/2025, 2:58:31 PM)

68.22

+0.9 (+1.34%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-09 2026-02-09/amc
Inst Owners95.68%
Inst Owner Change4.04%
Ins Owners6.45%
Ins Owner Change-6.98%
Market Cap16.53B
Revenue(TTM)2.48B
Net Income(TTM)-32.00M
Analysts74.19
Price Target90.67 (32.91%)
Short Float %8.11%
Short Ratio4.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.54%
Min EPS beat(2)-7.26%
Max EPS beat(2)0.18%
EPS beat(4)2
Avg EPS beat(4)-1.47%
Min EPS beat(4)-7.26%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)15.83%
EPS beat(12)10
Avg EPS beat(12)58.09%
EPS beat(16)14
Avg EPS beat(16)70.28%
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.18%
Max Revenue beat(2)-0.78%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)-0.3%
Revenue beat(8)4
Avg Revenue beat(8)1.16%
Revenue beat(12)8
Avg Revenue beat(12)2.19%
Revenue beat(16)10
Avg Revenue beat(16)-4.77%
PT rev (1m)0.42%
PT rev (3m)8.76%
EPS NQ rev (1m)3.4%
EPS NQ rev (3m)2.36%
EPS NY rev (1m)1.11%
EPS NY rev (3m)-1.87%
Revenue NQ rev (1m)0.95%
Revenue NQ rev (3m)1.29%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)0.88%
Valuation
Industry RankSector Rank
PE 44.88
Fwd PE 30.49
P/S 6.66
P/FCF 110.92
P/OCF 39.54
P/B 3.31
P/tB 8.72
EV/EBITDA 84.53
EPS(TTM)1.52
EY2.23%
EPS(NY)2.24
Fwd EY3.28%
FCF(TTM)0.62
FCFY0.9%
OCF(TTM)1.73
OCFY2.53%
SpS10.25
BVpS20.61
TBVpS7.83
PEG (NY)1.96
PEG (5Y)N/A
Graham Number26.55
Profitability
Industry RankSector Rank
ROA -0.56%
ROE -0.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.87%
FCFM 6%
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.83
Debt/EBITDA 1.57
Cap/Depr 102.28%
Cap/Sales 10.83%
Interest Coverage N/A
Cash Conversion 241.62%
Profit Quality N/A
Current Ratio 3.63
Quick Ratio 3.63
Altman-Z 14.3
F-Score7
WACC8.35%
ROIC/WACCN/A
Cap/Depr(3y)73.5%
Cap/Depr(5y)73.95%
Cap/Sales(3y)7.76%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
EPS Next Y22.85%
EPS Next 2Y27.79%
EPS Next 3Y29.97%
EPS Next 5Y30.58%
Revenue 1Y (TTM)15.17%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.35%
Revenue Next Year15.76%
Revenue Next 2Y14.95%
Revenue Next 3Y14.6%
Revenue Next 5Y14.16%
EBIT growth 1Y57.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year428.57%
EBIT Next 3Y95.63%
EBIT Next 5Y58.6%
FCF growth 1Y-21.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.75%
OCF growth 3YN/A
OCF growth 5YN/A

ZILLOW GROUP INC - C / Z FAQ

What is the ChartMill fundamental rating of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a fundamental rating of 5 / 10 to Z.


What is the valuation status for Z stock?

ChartMill assigns a valuation rating of 3 / 10 to ZILLOW GROUP INC - C (Z). This can be considered as Overvalued.


How profitable is ZILLOW GROUP INC - C (Z) stock?

ZILLOW GROUP INC - C (Z) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ZILLOW GROUP INC - C (Z) stock?

The Price/Earnings (PE) ratio for ZILLOW GROUP INC - C (Z) is 44.88 and the Price/Book (PB) ratio is 3.31.


Can you provide the expected EPS growth for Z stock?

The Earnings per Share (EPS) of ZILLOW GROUP INC - C (Z) is expected to grow by 22.85% in the next year.